Palvella Therapeutics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: PVLA
Share price (6/1/26): $112.59
Market cap (6/1/26): $1.615 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 89 pages Agreement and Plan of Merger by and Among Pieris Pharmaceuticals, Inc., Polo Merger Sub, Inc. and Palvella Therapeutics, Inc. Dated as of July 23, 2024

from 425 89 pages Agreement and Plan of Merger by and Among Pieris Pharmaceuticals, Inc., Polo Merger Sub, Inc. and Palvella Therapeutics, Inc. Dated as of July 23, 2024

from 8-K 36 pages Acquisition Agreement